These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 17411619)
1. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome. Kott B; Dubinsky TJ J Am Coll Radiol; 2004 Jun; 1(6):415-21. PubMed ID: 17411619 [TBL] [Abstract][Full Text] [Related]
2. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population]. Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315 [TBL] [Abstract][Full Text] [Related]
3. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105 [TBL] [Abstract][Full Text] [Related]
4. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome. Odibo AO; Stamilio DM; Nelson DB; Sehdev HM; Macones GA Obstet Gynecol; 2005 Sep; 106(3):562-8. PubMed ID: 16135588 [TBL] [Abstract][Full Text] [Related]
5. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
7. First trimester predictors of adverse pregnancy outcomes. Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038 [TBL] [Abstract][Full Text] [Related]
8. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years. Biggio JR; Morris TC; Owen J; Stringer JS Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005 [TBL] [Abstract][Full Text] [Related]
9. Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop. Reddy UM; Mennuti MT Obstet Gynecol; 2006 Jan; 107(1):167-73. PubMed ID: 16394055 [TBL] [Abstract][Full Text] [Related]
10. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening. Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324 [TBL] [Abstract][Full Text] [Related]
11. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects. Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004 [TBL] [Abstract][Full Text] [Related]
12. First trimester Down syndrome screening: public health implications. Fuchs KM; Peipert JF Semin Perinatol; 2005 Aug; 29(4):267-71. PubMed ID: 16104680 [TBL] [Abstract][Full Text] [Related]
13. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population. Bahado-Singh R; Oz U; Shahabi S; Omrani A; Mahoney M; Cole L Obstet Gynecol; 2000 Jun; 95(6 Pt 1):889-94. PubMed ID: 10831986 [TBL] [Abstract][Full Text] [Related]
14. Economic modelling of antenatal screening and ultrasound scanning programmes for identification of fetal abnormalities. Ritchie K; Bradbury I; Slattery J; Wright D; Iqbal K; Penney G BJOG; 2005 Jul; 112(7):866-74. PubMed ID: 15957985 [TBL] [Abstract][Full Text] [Related]
15. Does vaginal bleeding influence first-trimester markers for Down syndrome? Heinig J; Steinhard J; Schmitz R; Nofer JR; Witteler R; Mosel A; Ahrens A; Kiesel L; Klockenbusch W Prenat Diagn; 2007 Apr; 27(4):312-6. PubMed ID: 17286311 [TBL] [Abstract][Full Text] [Related]
16. First- and second-trimester Down syndrome screening: current strategies and clinical guidelines. Shaw SW; Hsu JJ; Lee CN; Hsiao CH; Chen CP; Hsieh TT; Cheng PJ Taiwan J Obstet Gynecol; 2008 Jun; 47(2):157-62. PubMed ID: 18603499 [TBL] [Abstract][Full Text] [Related]
17. Women as moral pioneers? Experiences of first trimester antenatal screening. Williams C; Sandall J; Lewando-Hundt G; Heyman B; Spencer K; Grellier R Soc Sci Med; 2005 Nov; 61(9):1983-92. PubMed ID: 15899542 [TBL] [Abstract][Full Text] [Related]
18. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory. Marical H; Douet-Guilbert N; Bages K; Collet M; Le Bris MJ; Morel F; De Braekeleer M Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510 [TBL] [Abstract][Full Text] [Related]
19. Cross-trimester marker ratios in prenatal screening for Down syndrome. Wald NJ; Bestwick JP; Morris JK Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232 [TBL] [Abstract][Full Text] [Related]
20. Options for Down syndrome screening: what will women choose? Grant SS J Midwifery Womens Health; 2005; 50(3):211-8. PubMed ID: 15894999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]